Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Histidine in Health and Disease: Metabolism, Physiological Importance, and Use as a Supplement

M. Holeček,

. 2020 ; 12 (3) : . [pub] 20200322

Language English Country Switzerland

Document type Journal Article, Review

Grant support
PROGRES Q40/02 Charles University

L-histidine (HIS) is an essential amino acid with unique roles in proton buffering, metal ion chelation, scavenging of reactive oxygen and nitrogen species, erythropoiesis, and the histaminergic system. Several HIS-rich proteins (e.g., haemoproteins, HIS-rich glycoproteins, histatins, HIS-rich calcium-binding protein, and filaggrin), HIS-containing dipeptides (particularly carnosine), and methyl- and sulphur-containing derivatives of HIS (3-methylhistidine, 1-methylhistidine, and ergothioneine) have specific functions. The unique chemical properties and physiological functions are the basis of the theoretical rationale to suggest HIS supplementation in a wide range of conditions. Several decades of experience have confirmed the effectiveness of HIS as a component of solutions used for organ preservation and myocardial protection in cardiac surgery. Further studies are needed to elucidate the effects of HIS supplementation on neurological disorders, atopic dermatitis, metabolic syndrome, diabetes, uraemic anaemia, ulcers, inflammatory bowel diseases, malignancies, and muscle performance during strenuous exercise. Signs of toxicity, mutagenic activity, and allergic reactions or peptic ulcers have not been reported, although HIS is a histamine precursor. Of concern should be findings of hepatic enlargement and increases in ammonia and glutamine and of decrease in branched-chain amino acids (valine, leucine, and isoleucine) in blood plasma indicating that HIS supplementation is inappropriate in patients with liver disease.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028365
003      
CZ-PrNML
005      
20210114153636.0
007      
ta
008      
210105s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/nu12030848 $2 doi
035    __
$a (PubMed)32235743
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Holeček, Milan $u Department of Physiology, Faculty of Medicine in Hradec Králové, Charles University, Šimkova 870, 500 38 Hradec Kralove, Czech Republic.
245    10
$a Histidine in Health and Disease: Metabolism, Physiological Importance, and Use as a Supplement / $c M. Holeček,
520    9_
$a L-histidine (HIS) is an essential amino acid with unique roles in proton buffering, metal ion chelation, scavenging of reactive oxygen and nitrogen species, erythropoiesis, and the histaminergic system. Several HIS-rich proteins (e.g., haemoproteins, HIS-rich glycoproteins, histatins, HIS-rich calcium-binding protein, and filaggrin), HIS-containing dipeptides (particularly carnosine), and methyl- and sulphur-containing derivatives of HIS (3-methylhistidine, 1-methylhistidine, and ergothioneine) have specific functions. The unique chemical properties and physiological functions are the basis of the theoretical rationale to suggest HIS supplementation in a wide range of conditions. Several decades of experience have confirmed the effectiveness of HIS as a component of solutions used for organ preservation and myocardial protection in cardiac surgery. Further studies are needed to elucidate the effects of HIS supplementation on neurological disorders, atopic dermatitis, metabolic syndrome, diabetes, uraemic anaemia, ulcers, inflammatory bowel diseases, malignancies, and muscle performance during strenuous exercise. Signs of toxicity, mutagenic activity, and allergic reactions or peptic ulcers have not been reported, although HIS is a histamine precursor. Of concern should be findings of hepatic enlargement and increases in ammonia and glutamine and of decrease in branched-chain amino acids (valine, leucine, and isoleucine) in blood plasma indicating that HIS supplementation is inappropriate in patients with liver disease.
650    _2
$a větvené aminokyseliny $x metabolismus $7 D000597
650    _2
$a amoniak $x metabolismus $7 D000641
650    _2
$a chelátory $7 D002614
650    _2
$a kontraindikace $7 D000075202
650    _2
$a atopická dermatitida $x terapie $7 D003876
650    12
$a potravní doplňky $7 D019587
650    _2
$a scavengery volných radikálů $7 D016166
650    _2
$a glutamin $x metabolismus $7 D005973
650    _2
$a histamin $7 D006632
650    12
$a histidin $x škodlivé účinky $x chemie $x fyziologie $x terapeutické užití $7 D006639
650    _2
$a lidé $7 D006801
650    _2
$a hypertrofie $x etiologie $7 D006984
650    _2
$a játra $x metabolismus $x patologie $7 D008099
650    _2
$a nemoci jater $x metabolismus $7 D008107
650    _2
$a metabolický syndrom $x terapie $7 D024821
650    _2
$a nemoci nervového systému $x terapie $7 D009422
650    _2
$a roztoky pro uchovávání orgánů $7 D019188
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
773    0_
$w MED00189563 $t Nutrients $x 2072-6643 $g Roč. 12, č. 3 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32235743 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114153633 $b ABA008
999    __
$a ok $b bmc $g 1608700 $s 1119545
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 12 $c 3 $e 20200322 $i 2072-6643 $m Nutrients $n Nutrients $x MED00189563
GRA    __
$a PROGRES Q40/02 $p Charles University
LZP    __
$a Pubmed-20210105

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...